Amrize (NYSE:AMRZ) Announces Earnings Results, Beats Estimates By $0.03 EPS

Amrize (NYSE:AMRZ) announced its quarterly earnings data on Tuesday. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03, Zacks reports.

Amrize Price Performance

NYSE:AMRZ traded down $1.39 during mid-day trading on Tuesday, reaching $57.44. 4,501,199 shares of the stock were exchanged, compared to its average volume of 3,339,046. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. The business has a fifty day moving average price of $55.50 and a 200 day moving average price of $52.18. Amrize has a 1-year low of $44.12 and a 1-year high of $60.57. The firm has a market capitalization of $31.77 billion and a PE ratio of 31.22.

Analyst Ratings Changes

AMRZ has been the subject of a number of research reports. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft set a $59.00 price objective on shares of Amrize in a research report on Monday, December 8th. UBS Group raised their target price on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, January 8th. Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price target on shares of Amrize in a research report on Thursday, December 18th. Finally, Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and boosted their price objective for the company from $56.00 to $60.00 in a research report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $60.75.

Insiders Place Their Bets

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. This trade represents a 67.61% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AMRZ. Itau Unibanco Holding S.A. raised its position in Amrize by 150.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares in the last quarter. US Bancorp DE bought a new position in shares of Amrize during the 3rd quarter valued at $38,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Amrize by 141.3% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock valued at $46,000 after purchasing an additional 496 shares during the last quarter. BNP Paribas Financial Markets acquired a new position in Amrize during the second quarter worth $59,000. Finally, CIBC Private Wealth Group LLC raised its holdings in Amrize by 143.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 1,419 shares of the company’s stock valued at $77,000 after buying an additional 835 shares in the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.